Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > RNXT RenovoRx > Detailed Quotes

RNXT RenovoRx

Watchlist
3.100
+0.080+2.65%
Close  02/03 16:00 ET
3.1000.0000.00%
Post Mkt Price 02/03 18:10 ET
High
3.250
Open
3.040
Turnover
133.17K
Low
2.950
Pre Close
3.020
Volume
42.87K
Market Cap
28.20M
P/E(TTM)
Loss
52wk High
5.000
Shares
9.10M
P/E(Static)
Loss
52wk Low
1.500
Float Cap
18.88M
Bid/Ask %
50.00%
Historical High
16.740
Shs Float
6.09M
Volume Ratio
2.21
Historical Low
1.500
Dividend TTM
--
Div Yield TTM
--
P/B
3.46
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.70%
Amplitude
9.93%
Avg Price
3.106
Lot Size
1
Float Cap
18.88M
Bid/Ask %
50.00%
Historical High
16.740
Shs Float
6.09M
Volume Ratio
2.21
Historical Low
1.500
Dividend TTM
--
P/B
3.46
Dividend LFY
--
Turnover Ratio
0.70%
Amplitude
9.93%
Avg Price
3.106
Lot Size
1
Price Forecast

News

Comment

Company Overview More
RenovoRx, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapy platform to deliver chemotherapy. Its therapy platform includes RenovoTAMP, a therapy platform designed for targeted delivery of chemotherapy enabling localized treatment of solid tumors. The company was founded by Ramtin Agah and Kamran Najmabadi in December 2009 and is headquartered in Los Altos, CA.
CEO: Mr. Shaun R. Bagai
Market: NASDAQ
Listing Date: 08/26/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist